International Journal of Colorectal Disease

, Volume 24, Issue 7, pp 731–740 | Cite as

Colorectal cancer screening in Europe: differences in approach; similar barriers to overcome

  • Nicholas J. West
  • Christian Boustière
  • Wolfgang Fischbach
  • Fabrizio Parente
  • Roger. J. Leicester
Review

Abstract

Worldwide diagnoses of bowel cancer approximate an estimated one million new cases per year, comprising 9% of all cancer cases, and this has continued to increase over the last 25 years. With the association between cancer risk and increasing age, together with the suggestion that by 2015 there will be a 22% increase in the proportion of the population aged over 65 years and a 50% increase in the proportion of people aged over 80 years, there is likely to be a significant increase in the demand on cancer services throughout Europe and the rest of the world. This article discusses the current state of bowel cancer screening within Europe.

Keywords

Colorectal cancer Bowel cancer Screening Bowel preparation 

References

  1. 1.
    Cancer Research UK (2007) Cancer worldwide. Available at http://info.cancerresearchuk.org/cancerstats/geographic/world/commoncancers/#source1. Last accessed 15 October 2007
  2. 2.
    Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592PubMedCrossRefGoogle Scholar
  3. 3.
    Cancer Research UK. UK bowel cancer statistics, 2006. Available at http://info.cancerresearchuk.org/cancerstats/types/bowel/a=5441. Accessed 18 September 2007
  4. 4.
    Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L et al (2007) Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol 8:784–796PubMedCrossRefGoogle Scholar
  5. 5.
    Jackman R, Mayo CW (1951) The adenoma–carcinoma sequence in cancer of the colon. Surg Gynecol Obstet 93:327–330PubMedGoogle Scholar
  6. 6.
    Muto T, Bussey HJ, Morson BC (1975) The evolution of cancer of the colon and rectum. Cancer 36:2251–2270PubMedCrossRefGoogle Scholar
  7. 7.
    Hardy RG, Meltzer SJ, Jankowski JA (2000) ABC of colorectal cancer. Molecular basis for risk factors. BMJ 321:886–889PubMedCrossRefGoogle Scholar
  8. 8.
    Winawer SJ (1999) Natural history of colorectal cancer. Am J Med 106:3S–6SPubMedCrossRefGoogle Scholar
  9. 9.
    Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW et al (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348:1472–1477PubMedCrossRefGoogle Scholar
  10. 10.
    Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348:1467–1471PubMedCrossRefGoogle Scholar
  11. 11.
    Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM et al (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328:1365–1371PubMedCrossRefGoogle Scholar
  12. 12.
    Kronborg O, Jorgensen OD, Fenger C, Rasmussen M (2004) Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 39:846–851PubMedCrossRefGoogle Scholar
  13. 13.
    Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ et al (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343:1603–1607PubMedCrossRefGoogle Scholar
  14. 14.
    Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD (2002) Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 50:840–844PubMedCrossRefGoogle Scholar
  15. 15.
    Hewitson P, Glasziou P, Irwig L, Towler B, Watson E (2007) Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev (1):CD001216Google Scholar
  16. 16.
    Atkin WS, Northover JM (2002) Population based endoscopic screening for colorectal cancer. Gut 52:321–322CrossRefGoogle Scholar
  17. 17.
    Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS (1992) A case–control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326:653–657PubMedGoogle Scholar
  18. 18.
    Lieberman DA, Weiss DG (2001) One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345:555–560PubMedCrossRefGoogle Scholar
  19. 19.
    Podolsky DK (2000) Going the distance—the case for true colorectal-cancer screening. N Engl J Med 343:207–208PubMedCrossRefGoogle Scholar
  20. 20.
    Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF (2000) Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343:169–174PubMedCrossRefGoogle Scholar
  21. 21.
    Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G (2000) Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343:162–168PubMedCrossRefGoogle Scholar
  22. 22.
    Parente F, Marino B, Armellino A, Redaelli L, Moretti R, Rossi G (2007) Mass screening of colorectal cancer with an immunochemical faecal occult blood test. Preliminary results in a pilot province. Gut 56(Suppl II):25Google Scholar
  23. 23.
    Cucino C, Buchner AM, Sonnenberg A (2002) Continued rightward shift of colorectal cancer. Dis Colon Rectum 45:1035–1040PubMedCrossRefGoogle Scholar
  24. 24.
    Cucino C, Parente F, Bianchi PG (2004) Rightward shift of colorectal cancer in Italy during the past three decades. Scand J Gastroenterol 39:783–786PubMedCrossRefGoogle Scholar
  25. 25.
    Kim DH, Pickhardt PJ, Taylor AJ, Leung WK, Winter TC, Hinshaw JL et al (2007) CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med 357:1403–1412PubMedCrossRefGoogle Scholar
  26. 26.
    Felix Burda Foundation (2007) The future of health in Europe. European Conference on Colon Cancer Prevention 2007. Available at http://burda.evisco.com/02_stiftung/2007-05-09_health-confernce2007/frameset.php?player=wmt&bandwidth=isdn2&video=2007-05-09_gernbauer&language=de. Accessed 18 December 2007
  27. 27.
    Department of Health. White paper: our healthier nation: saving lives. CM 4386, London. (CM 4386, London). 1999Google Scholar
  28. 28.
    Department of Health (2000) NHS cancer plan. Available at http://image.guardian.co.uk/sys-files/Society/documents/2003/08/26/cancerplan.pds. Accessed 18 September 2007
  29. 29.
    The UK CRC Screening Pilot Evaluation Team (2003) Evaluation of the UK colorectal cancer screening pilotGoogle Scholar
  30. 30.
    Lieberman DA (1995) Cost-effectiveness model for colon cancer screening. Gastroenterology 109:1781–1790PubMedCrossRefGoogle Scholar
  31. 31.
    Friedemann-Sanchez G, Griffin JM, Partin MR (2007) Gender differences in colorectal cancer screening barriers and information needs. Health Expect 10:148–160PubMedCrossRefGoogle Scholar
  32. 32.
    Vernon SW, Acquavella JF, Yarborough CM, Hughes JI, Thar WE (1990) Reasons for participation and nonparticipation in a colorectal cancer screening program for a cohort of high risk polypropylene workers. J Occup Med 32:46–51PubMedCrossRefGoogle Scholar
  33. 33.
    Vernon SW (1997) Participation in colorectal cancer screening: a review. J Natl Cancer Inst 89:1406–1422PubMedCrossRefGoogle Scholar
  34. 34.
    Harewood GC, Wiersema MJ, Melton LJIII (2002) A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 97:3186–3194PubMedCrossRefGoogle Scholar
  35. 35.
    Lichtenstein GR, Cohen LB, Uribarri J (2007) Review article: bowel preparation for colonoscopy—the importance of adequate hydration. Aliment Pharmacol Ther 26:633–641PubMedCrossRefGoogle Scholar
  36. 36.
    Hsu CW, Imperiale TF (1998) Meta-analysis and cost comparison of polyethylene glycol lavage versus sodium phosphate for colonoscopy preparation. Gastrointest Endosc 48:276–282PubMedCrossRefGoogle Scholar
  37. 37.
    Ell C, Fischbach W, Keller R, Dehe M, Mayer G, Schneider B et al (2003) A randomized, blinded, prospective trial to compare the safety and efficacy of three bowel-cleansing solutions for colonoscopy (HSG-01*). Endoscopy 35:300–304PubMedCrossRefGoogle Scholar
  38. 38.
    Ell C, Fischbach W, Bronisch HJ, Dertinger S, Layer P, Runzi M et al (2008) Randomized trial of low-volume PEG solution versus standard PEG+electrolytes for bowel cleansing before colonoscopy. Am J Gastroenterol 103:883–893PubMedCrossRefGoogle Scholar
  39. 39.
    Froehlich F, Wietlisbach V, Gonvers JJ, Burnand B, Vader JP (2005) Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of appropriateness of gastrointestinal endoscopy European multicenter study. Gastrointest Endosc 61:378–384PubMedCrossRefGoogle Scholar
  40. 40.
    Harewood GC, Sharma VK, de Garmo P (2003) Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc 58:76–79PubMedCrossRefGoogle Scholar
  41. 41.
    Rex DK, Imperiale TF, Latinovich DR, Bratcher LL (2002) Impact of bowel preparation on efficiency and cost of colonoscopy. Am J Gastroenterol 97:1696–1700PubMedCrossRefGoogle Scholar
  42. 42.
    Kim WH, Cho YJ, Park JY, Min PK, Kang JK, Park IS (2000) Factors affecting insertion time and patient discomfort during colonoscopy. Gastrointest Endosc 52:600–605PubMedCrossRefGoogle Scholar
  43. 43.
    Bowles CJ, Leicester R, Romaya C, Swarbrick E, Williams CB, Epstein O (2004) A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut 53:277–283PubMedCrossRefGoogle Scholar
  44. 44.
    Mandelson MT, Curry SJ, Anderson LA, Nadel MR, Lee NC, Rutter CM et al (2000) Colorectal cancer screening participation by older women. Am J Prev Med 19:149–154PubMedCrossRefGoogle Scholar
  45. 45.
    Weitzman ER, Zapka J, Estabrook B, Goins KV (2001) Risk and reluctance: understanding impediments to colorectal cancer screening. Prev Med 32:502–513PubMedCrossRefGoogle Scholar
  46. 46.
    Lemon SC, Zapka JG, Estabrook B, Erban S, Luckmann R (2003) Screening for colorectal cancer on the front line. Am J Gastroenterol 98:915–923PubMedCrossRefGoogle Scholar
  47. 47.
    Solberg LI, Kottke TE, Conn SA, Brekke ML, Calomeni CA, Conboy KS (1997) Delivering clinical preventive services is a systems problem. Ann Behav Med 19:271–278PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Nicholas J. West
    • 1
  • Christian Boustière
    • 2
  • Wolfgang Fischbach
    • 3
  • Fabrizio Parente
    • 4
  • Roger. J. Leicester
    • 5
  1. 1.Endoscopy DepartmentSt George’s HospitalLondonUK
  2. 2.Gastrointestinal, Endoscopic UnitSt Joseph HospitalMarseillesFrance
  3. 3.Internal Medicine, Academic Teaching HospitalUniversity of WürzburgWürzburgGermany
  4. 4.GastroenterologyA. Manzoni HospitalLeccoItaly
  5. 5.Endoscopy DepartmentSt George’s HospitalLondonUK

Personalised recommendations